INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $1,003,000 | -30.8% | 118,700 | -10.3% | 0.00% | -50.0% |
Q2 2015 | $1,449,000 | -38.7% | 132,305 | -21.7% | 0.00% | -33.3% |
Q1 2015 | $2,362,000 | -5.6% | 168,989 | +14.1% | 0.00% | 0.0% |
Q4 2014 | $2,501,000 | +193.2% | 148,086 | +203.1% | 0.00% | +200.0% |
Q3 2013 | $853,000 | +14.5% | 48,860 | +6.5% | 0.00% | 0.0% |
Q2 2013 | $745,000 | – | 45,860 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |